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Executive Summary
Total knee arthroplasty (TKA) and total hip arthroplasty (THA) are surgical procedures
performed for painful, dysfunctional joints most often caused by osteoarthritis. These procedures
are increasing in demand for not just the elderly, but young adults as well. They are elective
procedures associated with a three to five gram decrease in hemoglobin postoperatively,
considered a major blood loss. International research results, verified by analysis of a 228 patient
sample from the system in this study, demonstrate that patients who enter these procedures with
anemia are more likely to require postoperative blood transfusions. With a decreasing supply due
to a shrinking donor pool and added costs due to stringent testing, allogeneic blood used for
transfusions demands that providers use stewardship with this precious resource. Autologously
donated blood as an option is falling out of favor because it further reduces the preoperative
hemoglobin, is costly, and unused units are wasted. Blood use for transfusions, whether
autologously donated or allogeneic, is associated with many risks including but not limited to
fluid volume overload, delayed wound healing, postoperative infections, and longer
hospitalizations. Anemia is an abnormal finding and, in the setting of elective surgical
procedures with major blood loss, should be corrected preoperatively to decrease the need for
blood transfusions. This change project describes interventions to increase red blood cells
preoperatively, weaving the interventions into an evidenced-based algorithm for consideration in
practice by members of the healthcare team. The evidence-based algorithm and study findings
will be shared with providers to invoke discussion on strategies for implementation and
evaluation. Furthermore, this project serves as an example of research-guided changes, designed
by a doctorally prepared nurse, capable of enhancing positive health care outcomes for both the
patient and the healthcare system.
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Background
This change project was born in a spirit of interdisciplinary inquiry. It originated in a
dialogue between an advanced practice nurse (APN) and an orthopedic surgeon regarding the
need for postoperative blood transfusions in patients who electively have total hip or total knee
replacement surgeries. Areas of discussion included: differences in observed procedural blood
loss versus postoperative hemoglobin levels; the management of preoperative anemia in this
patient population; the risks involved with blood transfusions; and the judicious use of blood as a
scarce resource. Questions raised by both providers inspired this research designed to clarify
whether current practice patterns align with evidence-based practice leading to optimum
outcomes for patients who opt to have elective total hip or total knee replacement surgeries.
The setting for the research is a Catholic health care system in the Midwest, which has
multiple hospitals where orthopedic procedures are performed. This particular health care system
has a service-based mission and vision steeped in social justice principles whereby communities
are offered compassionate patient service and clinical excellence. This particular research study
aligns with the system strategic goals of clinical excellence and stewardship. Clinical excellence
is defined as valuing superior performance, exceeding expectations, seeking continuous ways to
improve care, meeting challenges and opportunities in a creative manner, and using the best
practices to help the organization achieve its goals with a spirit of teamwork. Stewardship is
defined as responsible use of human, financial, and natural resources entrusted for the common
good, with special attention to the poor.
A review of the literature provides the basis for clinical excellence in care of patients who
elect to have total hip or total knee replacement surgery specifically as it relates to preoperative
anemia and the utilization of postoperative blood transfusions. Data collection and analysis of
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practice patterns utilized in this healthcare system for patients who have total knee arthroplasty
(TKA) and total hip arthroplasty (THA) procedures provides real life information from which to
compare. Analysis of results guides recommendations for appropriate, minimal, safe, and costeffective utilization of blood, which will help ensure that the call for stewardship is fulfilled.
Project objectives
The objectives for this change project are as follows:
1. Utilize patient data to analyze preoperative anemia and postoperative transfusions
associated with elective THA and TKA
2. Review relevant literature on preoperative anemia and its impact on postoperative blood
transfusions associated with TKA and THA elective procedures
3. Create an algorithm to address preoperative anemia for patients who elect to have TKA
and THA surgical procedures based on identified gaps between study findings and the
literature
4. Stimulate interdisciplinary inquiry into health care practices by sharing this project with
members of the orthopedic and healthcare community
5. Fulfill requirements for a Doctorate in Nursing change project while demonstrating how
this role can be utilized to improve patient care
Challenges
Healthcare in our country is referred to as a system. The structure of the healthcare
system is complex in nature and not well understood. Healthcare providers, who represent what
should be inter-connective parts of the system, often operate in isolation, devoid of
communication with other team members. Interdisciplinary communication is critical to the
improvement of patient outcomes. Herein lay the challenges for this change project, namely, the
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need to stimulate system players to work together, while developing a sense of inquiry into
practices that improve the quality of the patient experience. This particular healthcare system has
multiple professionals at multiple sites performing these orthopedic procedures. The sites are in
the process of becoming integrated.
Research Questions
The study was designed to answer the following specific research questions:
1. Is there a relationship between preoperative anemia and the use of postoperative blood
transfusions?
2. What risk factors are associated with postoperative blood transfusions?
3. Is there a change in postoperative hemoglobin levels by surgical type over the initial
postoperative days?
Summary
Following a review of current literature and the study of a sample of surgical patients,
this research will culminate in the design of an algorithm for preoperative care of patients with
anemia who elect to have TKA and/or THA within this healthcare system. This practice tool will
be shared with members of the orthopedic community for consideration. It is one of many steps,
which, if instituted, can improve blood management for these and other elective surgical
procedures.
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Theoretical Framework
Strategizing for structural change within the organization demands a theoretical
framework that can be applied to both the individual and the team as a whole. In order to obtain
synergistic energy from a team, it is essential for individuals to grow in self-actualizing skills at
the same time the team is developing mutual actualizing talents. The Human Systems theory
represents a formula to help both individuals and team members succeed.
Hanlon (1968) devoted his career to the development of a Human Systems Theory to
guide education and administration. Sinnen (1981) furthered the work of Hanlon by defining the
profession of nursing with a nurturance theory and model based on the Human Systems Theory.
Human Systems Theory involves seven basic human operations: learning, creation of worldview,
creation of ideal pattern, conceptualization, climate creation, environment creation, and
cybernetics. In the educational realm, the mastery of these processes leads to self-actualization
for the individual. The role of the educator is to assist the individual in this process of mastery.
Likewise, the mastery of these same seven human processes at the group level leads to
synergistic behaviors. The role of the administrator is to assist groups to reach this level of
actualization. The role of the advanced practice nurse is that of the educator, nurturing patients
toward mastery of these seven human operations. Additionally, the advanced practice nurse is
prepared to assume the role of administrative leader assisting healthcare teams to actualize
common learnings which inform the operations of worldview and ideal pattern construction so
that decision making, problem solving, planning, and evaluation (conceptualization) can be
accomplished for the benefit of improvements in patient care. With that common foundation, the
operations of creating a climate and environment specifically designed for the patient by the
healthcare team can become a reality. The work involved in creating a healthcare team that can
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actualize, in essence, practice at the level of cybernetic mastery is intense, but so are the rewards
for all involved with results benefiting patient care.
The absence of this administrative leadership is evident in health care today.
Fragmentation of care, failure to institute best practice measures into care, inconsistent
outcomes, and lack of coordinated communication between health care team members are some
of the more noted observations. In order to improve healthcare, it is imperative that health care
leaders understand and work with teams to actualize the seven basic operations. It is only
through such strategies that systems of care and patient outcomes will experience lasting
improvements.
This project seeks to increase teamwork involved in the care of patients who elect to have
THA or TKA. The focus is improving systems of care involved in anemia management for this
group of patients. The goal is to stimulate team learning and create a common worldview woven
from inquiry, a common ideal pattern, common conceptualization within a climate, and an
environment consistent with optimal patient outcomes. After comparing best practice standards
recommended in the literature with current practice patterns, it will be up to the team to make
decisions based on analysis of identified discrepancies, to initiate appropriate changes, and to
develop a plan to evaluate the results while moving forward with further inquiries into practice.
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Review of the Literature
Paramount to improving systems to manage preoperative anemia for patients who
electively have TKA or THA procedures is an understanding of pertinent literature. This review
of the literature explores preoperative anemia, TKA and THA procedures, and the impact of
preoperative anemia on the utilization of blood transfusions in the postoperative phase of patient
care.
Significance of Preoperative Anemia
Anemia is defined as lack of sufficient healthy red blood cells in the body and is detected
by serum hemoglobin levels (National Anemia Action Council, 2009). Hemoglobin is
responsible for carrying oxygen from the lungs throughout the body. Anemia can be acute
accompanying a major episode of bleeding or chronic as seen with slower bleeds, vitamin or iron
deficiencies, and in association with chronic disease (National Anemia Action Council, 2009).
Symptoms depend on the degree of anemia and may include fatigue, shortness of breath or chest
pain with exertional activities, dizziness, anorexia, or depression (National Anemia Action
Council, 2009). Signs of anemia can include pale skin, brittle nails, coldness of extremities,
murmur, and irregular heartbeats (National Anemia Action Council, 2009). Mild forms of
anemia respond easily to treatment while more severe and long lasting forms left undiagnosed
and untreated can be life threatening (National Anemia Action Council, 2009). The World
Health Organization (2008) identifies anemia as a hemoglobin level of less than 13 g/dL in adult
men and less that 12 g/dL in adult non-pregnant females. Iron deficient anemia (IDA), the most
prevalent form of anemia, has been associated with delayed cognitive development and poor
physical performance. IDA is a major factor contributing globally to the burden of disease
(World Health Organization, 2008). In an analysis of the literature on IDA, Killip, Bennett and
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Chambers (2007) elaborate on causes stemming from inadequate dietary intake of iron,
malabsorption of iron, or losses in women of reproductive age. They link IDA prevalence to
gender and ethnicity, reporting a prevalence of 2% in adult men, 9-12% in non-Hispanic white
women, and nearly 20% in Black and Mexican-American women (Killip, et al., 2007 p. 675).
Anemia is more common in the elderly but it is not a consequence of the normal aging process
(Holdener & Liang, 2007). Anemia is an abnormal laboratory result reflective of a clinical
condition that warrants attention.
Anemia represents a substantial economic burden. In a study designed to examine the
economic impact of anemia, Ershler, Chen, Reyes and Dubois (2005) looked at a managed care
patient population and compared patients with anemia associated with six identified chronic
conditions with patients in a nonanemic cohort. Direct and indirect health care costs as well as
impact of work productivity were calculated and, once demographic differences were adjusted
for, those with anemia had substantially higher costs. Based on the results, the authors estimated
that per one million lives, those with anemia related to these identified chronic conditions incur
$110 million greater costs. Those responsible for the care of patients with anemia are urged to
identify and correct this condition for both clinical and economic reasons (Ershler, et al., 2005).
The World Health Organization (2008) defines anemia as less than 12.0 g/dL for females
as and less than 13.0 g/dL in males. Preoperative hemoglobin levels greater than 13.0 g/dL for
TKA and THA correlate to fewer transfusions. Keating, Meding, Faris, and Ritter (1998),
conducted research in an effort to better understand factors associated with transfusions for
patients who electively have knee replacement surgery. The results of this study demonstrated
that preoperative hemoglobin levels, pre-donation hemoglobin levels, and estimated blood
volume negatively correlate with risk of transfusions for patients in both unilateral and bilateral
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knee replacement surgeries. Joint replacement surgery involves significant blood loss. A drop in
hemoglobin level of 3.85 g/dl was associated with unilateral knee surgery, while those who had
bilateral knee replacement surgery experienced an average hemoglobin drop of 5.42 g/dL. The
patient group with preoperative hemoglobin levels greater than 13 g/dL had only an 8% chance
of transfusion. Those considered anemic with preoperative hemoglobin levels less than 13 g/dL
had a 30 % chance of transfusions. Patients who donated autologous units prior to surgery had an
11.6 % chance of receiving allogeneic transfusions and a 50% chance of receiving their
autologous units (Keating, et al., 1998).
Preoperative anemia has been associated with poor patient outcomes including death.
Anemic elderly patients with underlying cardiovascular disease are notably at higher risk of
complications (Kumar & Carson, 2008). Prudent preoperative care involves a thorough history
and physical, diagnostic testing for evaluation of cause of anemia, and correction of the condition
(Kumar & Carson, 2008.) It is recommended that a hemoglobin level is obtained thirty days
before the surgical procedure with a thorough analysis of unexplained anemia leading to
postponing of elective surgery if necessary (Goodnough, et al., 2005).
Total Hip and Total Knee Arthroplasty
Total hip arthroplasty (THA) and total knee arthroplasty (TKA) are elective surgical
procedures done to relieve chronic pain, recover joint function, and improve quality of life for
those who suffer from joint failure caused by osteoarthritis (OA), rheumatoid arthritis (RA), or
other chronic inflammatory processes (Liang, et al., 1986). The demand for these procedures is
increasing. In a 2007 update of adult reconstructive surgical procedures, Lonner and
Deirmengian (2007) noted a 400% increase in TKA procedures from 1971 to 2003, with
adjustment for age and gender. Total hip arthroplasty procedures during that timeframe increased
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by 55%. Projections include a 600% increase in TKA and 137% for THA procedures, between
2005 and 2030. This review also noted that osteoarthritis has replaced rheumatoid arthritis as the
predominate diagnosis for THA and TKA procedures, while a younger patient population is
being treated, with the largest percentage of increase seen in those less than fifty years of age
(Lonner & Deirmengian, 2007). Anticipating the increase in numbers of patients seeking these
surgical procedures it becomes important to focus on economic resources and improvements in
operational efficiencies (Lonner & Deirmengian, 2007).
One of the greatest challenges to improving operational efficiencies and enhancing
patient outcomes for THA and TKA procedures involves the management of associated blood
loss. While visible blood losses are recorded, the numbers underestimate true losses. The term
‘hidden losses’ has been coined to describe additional blood losses accounting for the drop in
hemoglobin levels seen postoperatively. In a review of 324 patient charts from 1987 through
1989, calculated blood losses of 3.2 + 1.3 units for a primary THA and 4.0 + 2.3 units for
revision procedures were noted. These losses were associated with transfusion rates of 2.0 + 1.8
units for primary and 2.9 + 2.3 units for revision THA procedures (Toy, Kaplan, McVay,
Strauss, & Stehling, 1992). Similarly, TKA procedures have hidden losses. Primary TKA are
linked to a 3.0 gm/dl drop in hemoglobin (Sehat, Evans, and Newman, 2004). The average
patient loses about 4 grams of hemoglobin after THA or TKA according to Keating and Ritter
(2002).
Transfusions add to the already high costs associated with these joint replacement
procedures. In reviewing the financial impact for primary TKA procedures, Cook, Warren,
Ganley, Prefontaine and Wylie (2008) noted Center for Medicare & Medicaid Services (CMS)
reimbursed over $2 billion in 2006. Of further concern is that CMS reimbursement is less than
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actual hospital bills, forcing some institutions to disallow these procedures from their list of
services due to the unfavorable finances (Cook, Warren, Ganley, Prefontaine & Wylie, 2008).
Transfusions
Elective surgeries that involve major blood loss can involve critical decision making
regarding the use of blood transfusions. The use of blood transfusions is unavoidable under
certain circumstances, there are clinical and financial reasons mandating a closer examination of
the use of transfusions with elective surgical procedures (Lemaire, 2008). The use of allogeneic
transfusions in elective procedures is of concern because, in parts of the country, blood is a
scarce resource with a notable shrinking donor pool. With the number of surgical patients on the
increase, decisions to transfuse require careful consideration by all members of the surgical team
(Monk, 2004). The blood supply is notably safer due to stringent testing, yet, blood transfusions
are associated with adverse effects, including but not limited to, transfusion reactions,
transmission of infectious disease, transfusion related acute lung injury, administrative errors,
and currently unknown side effects (Lemaire, 2008). There are concerns that blood transfusions
cause immunosuppression, thought to increase the risk of postoperative infection, delay wound
healing, and prolong hospitalization. The medical community believes that the risk of
immunosuppression from transfusions is real and linked with adverse clinical outcomes (Spahn
& Casutt, 2000). These concerns have resulted in a process of leukocyte depletion for allogeneic
blood (Slappendel, Dirksen, Weber & van der Schaaf, 2003). Leukocyte depletion is a process
aimed at meditating the effects of allogeneic transfusions on the immune system. Additional
research is investigating the changes that red blood cells undergo when exposed to cold storage.
Koch, et.al., (2008) compared the effects of old blood, stored more than 14 days, with newer
blood on 2872 patients who had cardiac surgery and required transfusions. The findings
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demonstrated a significant increase in the risk of postoperative complications and in short-term
and long-term mortality in those who were transfused with blood stored longer than two weeks
(Koch, et. al, 2008).
There are two forms of blood transfusions. Autologous blood is donated by patients in
advance of their surgical procedure, placed in cold storage, and transfused back if and when
needed. Allogeneic, the most common type of transfusion, is donated, undergoes rigorous
testing, and is placed in cold storage and made available to the public. All blood transfusions
have associated risks and can be correlated with a greater chance of infection, fluid overload, and
prolonged hospital stays (Kumar, 2009). The surgical team is urged to use interventions that limit
transfusions, conserve blood, and correct preoperative anemia in order to improve surgical
outcomes (Monk, 2004). To that end, the concept of “bloodless medicine” has become more
popular (Kickler, 2003). “Bloodless medicine” refers to clinical strategies for patient care
designed to avoid allogeneic blood transfusions (Goodnough, Shander, & Spence, 2003). It is
one area of blood management programs that have been established worldwide (Kickler, 2003).
Blood management techniques have grown because of treating patients who have refused blood
products due to religious beliefs (e.g. Jehovah witness) or other reasons. This has stimulated a
belief that minimizing transfusions represents quality and safe care that should be available to all
patients (Shander & Goodnough, 2006). Blood conservation strategies are described as falling
within three pillars of impact: those interventions which augment preoperative red blood cell
mass; those interventions which reduce surgical blood loss; and, the acceptance of lower
hemoglobin levels (Gombotz, Rehak, Shander, & Hofmann, 2007).
Autologous blood donation. Autologous blood donation (PAD) is a controversial option
to blood management for patients who electively have THA or TKA procedures. While still an
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option, there is growing concern related to the inconvenience, cost, waste, and preoperative
anemia associated with this intervention (Pierson, Hannon, & Earles, 2004). Unused autologous
units cannot enter the blood center supply because of policy and laws. Therefore, unused PAD
units are wasted, leading to concerns about efficient resource utilization. Autologous transfusions
hold the same risk profile of allogeneic transfusions. These include administration errors, risk of
postoperative infection, fluid overload, and the risks associated with impair red blood cells
altering the delivery of oxygen to tissues, potentially adding to the systemic burden of
inflammation (Boucher & Hannon, 2007).
Keating and colleagues (1998) reviewed the hospital records of 279 patients who had
either unilateral or bilateral knee replacement procedures. The sample included patients who
participated in the autologous donation program and those who did not. Those who participated
in the autologous donation program had a notable 76% of their donated blood wasted. A logistic
regression analysis was performed on a variety of data elements to determine the independent
predictors for transfusions for this patient population. This research culminated in the design of a
critical pathway with specific emphasis on correction of preoperative anemia as the most
important factor influencing the use of allogeneic blood transfusions in knee replacement
surgeries (Keating, et al., 1998).
Similarly, Hatzidakis, Mendlick, McKillip, Reddy, and Garvin (2000) sought to analyze
risk factors for allogeneic transfusions and appropriate strategies for the use of autologous
donation in total joint arthroplasty in their Nebraska setting. Employing a retrospective chart
audit of 489 consecutive patients who had total joint arthroplasty procedures and logistic
regression analysis of several factors, they were able to clarify patients at lowest risk of
transfusions. Like the other studies, lower preoperative hemoglobin was associated with the
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need for allogeneic transfusions. The results link the type of surgery performed, age of the
patient, and the preoperative hemoglobin level as factors for identifying those at most risk for
transfusions with total arthroplasty procedures. Patients with minimal risk of needing
transfusions have higher initial hemoglobin (130 to 150 grams per liter), are less than sixty-five
years of age, and are scheduled for primary joint replacement surgery. While the authors
continue to recommend the use of PAD, patients in the minimal risk category are provided better
information to aid in deciding if the PAD program is worth the associated effort (Hatzidak, et al.,
2000).
Using prospective, randomized methodology, Billote, Glisson, Green and Wixson (2002)
studied patients scheduled for primary total hip surgery with a preoperative hemoglobin level >
120 g/L, dividing a group of 96 into those who donated autologous units and those who did not
donate. There were no significant differences noted in demographics of the donors and nondonors or blood-loss volumes associated with the surgical procedures. Neither group required an
allogeneic transfusion. Twenty-nine of the 42 patients (69%) who participated in PAD received
an autologous transfusion postoperatively. The authors concluded that for nonanemic patients
undergoing a primary total hip surgery there is no benefit in PAD, in fact donation increased the
use of autologous transfusions, wasting of units, and the cost associated with the procedure
(Billote, et al., 2002).
PAD programs remain in vogue for elective surgery due to public perception that the
allogeneic blood supply is unsafe. When used inappropriately, PAD contributes to preoperative
anemia which is the most important factor linked to postoperative transfusions. PAD units may
be transfused perioperatively simply because they are available, not necessarily because they are
needed. It is important for providers to understand the evidence and published guidelines behind
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PAD as a practice option, to utilize it with careful preoperative planning, and to help educate the
public on the economic impact involved in this process (Keating & Meding, 2002). While the
practice of PAD is on the decline, it is still considered a useful option in those with multiple
antibodies making donor blood difficult to obtain (Kumar, 2009).
The Impact of Anemia on Recovery
The postoperative period for some patients who have TKA or THA procedures includes
admission to an inpatient rehabilitation unit to maximize function of the joint in a supervised
setting. Lower hemoglobin levels affect the patient’s ability to participate in physical therapy.
This was the research topic of a retrospective study of 184 patients admitted to an acute
rehabilitation facility from 2001 to 2003. The study, funded by Ortho Biotech, measured patient
function using the Functional Independence Measure (FIM) Instrument and through multivariate
analysis, correlated length of stay, hemoglobin levels, and changes in FIM scores (Diamond,
Conaway, Mody, & Bhirangi, 2006). Findings from this study verify that a higher baseline
hemoglobin level is associated with a shorter length of stay and faster functional gains. While
additional studies such as this one are recommended, the results further confirm that strategies,
which limit blood loss and increase hemoglobin levels in this population affect the entire patient
experience (Diamond, Conaway, Mody, & Bhirangi, 2006). Of concern are the interventions that
help maximize hemoglobin levels in a safe, efficient, and cost effective manner.
Summary
Anemia is an abnormal condition that influences the quality of life for many persons and
preoperatively leaves patients vulnerable for postoperative transfusions. Those found to be at
greatest risk include women, particularly Black and Mexican-American women, the elderly, and
those with chronic comorbid conditions. Transfusions are associated with complications, costs,
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and longer hospitalizations. TKA and THA are surgical procedures electively selected by
patients to improve mobility, functionality, and quality of life. These procedures are associated
with major blood loss. Optimizing preoperative hemoglobin levels decreases the chance for
transfusions in the postoperative surgical phase of TKA and THA procedures.
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Project Design and Methodology
Project Design
This descriptive change project was designed to examine preoperative anemia and
postoperative transfusions associated with elective THA or TKA procedures for patients in one
system, to compare findings to recommendations in relevant literature, and to make
recommendations for practice changes based on a gap analysis. The setting for this study was a
Midwest multi-hospital health care system. A retrospective chart audit was the method used to
collect data to examine the relationship between preoperative anemia and postoperative blood
transfusions, to identify other risk factors associated with postoperative blood transfusions, and
to ascertain if there is a change in hemoglobin levels associated with these procedures in the
initial postoperative days.
Approval for this study was obtained from the Institutional Review Boards (IRB) of St.
Catherine University as well as the healthcare system prior to beginning the data collection
portion of the research study. The study was retrospective in nature. The information technology
department (IT) completed a data search. The results of this search identified patients who
elected to have TKA or THA procedures at one of three acute care sites within the healthcare
system over a three-month timeframe between January 1, 2009 and March 31, 2009. The total
number of patients noted from the initial data pull was 235 patients, of which 228 patients met
inclusion criteria. Patients age eighteen and older who had unilateral or bilateral, primary or
revision total knee or total hip surgical procedures were included in the database. Several
patients had only partial procedures and were therefore excluded. Informed consent for
participation in this research was incorporated into the signed surgical consent. The consent
gives permission for medical education or scientific research as long as the patient cannot be
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identified in the research. It is assumed that the consent form was reviewed in a patient exchange
prior to surgery and that the patient fully understood the information.
A review of the literature revealed the data elements worth collecting. A codebook for
data collection was designed using the identified variables (see Appendix A). These elements
include patient demographics, pre and postoperative hemoglobin and hematocrit levels, number
of autologous or allogeneic blood transfusion utilized, length of stay, and financial data
associated with the hospitalization for the surgical procedures. An associate from the data
management department assisted in the development of excel spreadsheets for the data collection
process. The author of the change project was the sole person involved in collecting the data. The
medical record number was the only patient identifier extracted from the electronic health chart.
A code number was assigned to each medical record number, after which the medical record
column was removed from the data set. A sheet containing the medical record number-code
number match is retained in a locked cabinet in the principal investigator’s office. This was
separated from the data analysis spreadsheet and analysis run sheets, and kept in a password
protected on-line folder. Only the principal investigator had access to the medical record number
information. Once the study was completed, the medical record-code number match sheet was
destroyed. The data used for analysis are secured and will be maintained by the principal
investigator for seven years, in accordance with IRB policy.
Methodology
Statistical Package for the Social Sciences (SPSS) program was used for data analysis.
The three research questions were analyzed in the following manner (Table 1):
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Table 1 Methodology for Analysis of Research Questions

Research Questions
Is there a relationship between preoperative
anemia and the use of postoperative blood
transfusions?
What risk factors are associated with
postoperative blood transfusions?
Is there a change in postoperative hemoglobin
levels by surgical type over the initial
postoperative days?

Data Analysis
Chi square analysis

Chi Square analysis
Repeated measures general linear model
analysis

Methodology for Enacting the Change Process
Key stakeholders are being informed of the findings and additional champions of the
change process are being identified. Results are being disseminated to interdisciplinary
colleagues with the goal of defining action steps for implementing the algorithm into practice.
Ongoing utilization of transfusions with TKA and THA will be aligned with the quality
department so that results of the change can be monitored. Additionally, in sharing this research,
it is hoped that team members will be stimulated to make other inquires into practice so that the
work of enhancing the patient experience is continually maximized and validated with evidenced
based knowledge.
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Data Analysis
This study sample included 228 surgical patients who had either TKA or THA
procedures within a three-month timeframe at one of several acute facilities in a Midwest
healthcare system. Demographic data for the patients in this retrospective study are synchronized
in Table 2. The sample was made up of one hundred and fifty-seven (69%) females and seventyone (31%) males ranging in age from 26 to 90 years of age with a mean age of sixty-five years.
The age variable was further grouped as listed in the table. The majority of the patients were
Caucasian / White (86%), had underlying hypertension (73%), and had total knee procedures
(66%). Some of the variables were reduced to dichotomous groupings due to limited numbers.
Table 2 Sample Population Demographics and Factors
Means

Ranges

Length of stay (in days)

3.35

1-8

Preoperative weight

90 kg

46 –210kg

Age
Categories:

65.1

26 – 90

Characteristics

< 50
51-65
66-79
80 +
Gender
Males
Females
Surgical procedures
Hip procedures
Knee procedures
Categories:
Unilateral (primary)THA
Unilateral (primary)TKA
Revision hip (RH)
Revision knee (RK)
Bilateral hip (BH)
Bilateral knee (BK)

N

%

21
93
92
22

(9)
(41)
(40)
(10)

71
157

(31)
(69)

77
151

(34)
(66)

73
139
4
9
0
3

(32)
(61)
(2)
(4)
(0)
(1)
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Co morbid conditions
Cardiovascular Disease
Hypertension
Rheumatoid arthritis
Diabetes Mellitus
Chronic Kidney Disease
Pulmonary Disease
Cancer
Hematological Disease
Liver Disease
Gastrointestinal Bleed
Neurological /
Cerebral Vascular Accident

68
167
7
42
21
51
24
11
6
5
12

(30)
(73)
(3)
(18)
(9)
(22)
(11)
(5)
(3)
(2)
(5)

3
17
0
20
14
11

(1)
(8)
0
(9)
(6)
(5)

Preoperative medications
Immunosuppressive agents
Anticoagulation agents
Epoetin alfa
IV or oral iron
IM or oral B12
Folic acid

Findings by Research Question
Research question 1. Was there a relationship between preoperative anemia and the use
of postoperative blood transfusions? Anemia was defined as females with a hemoglobin level
less than 12.0 g/dL and males with a hemoglobin level less than 13.0 g/dL. Using a Chi Square
analysis, the findings support a statistically significant relationship between preoperative anemia
and the use of postoperative blood transfusions in this patient sample. Of the 40 subjects who
were anemic, 30 (75%) were treated with postoperative blood transfusions (χ 2= 33.93; p< .001),
as shown in Table 3 and further illustrated in Figure 1. Of the 188 subjects without preoperative
anemia, 50 (26.6%) were transfused. There was no identified standard protocol for postoperative
transfusion criteria.

Running head: ANEMIA MANAGEMENT AND TOTAL JOINT SURGERIES

29

Table 3 Chi Square Analysis of Relationship between Preoperative Anemia and Postoperative
Transfusions
Preoperative Anemia n (%)
No
Yes

Total

Transfused
Postoperatively
No
Yes
Totals
χ = 33.93, p < .001

138 (73.4)
50 (26.6)
188

10 (25)
30 (75)
40

148 (64.9)
80 (35.1)
228

2

Figure 1 Comparison of Preoperative Anemia to Postoperative Transfusions

200
180

Total Sample (n= 228 Patients)

160
140
138

120
100
80

No Transfusion

60

Post Op Tranfusion

40

10

20

30

50
0

Pre Op Anemia

No Pre Op Anemia

(χ2=33.93; p < .001)
Comparison in sample of preoperative
anemia to postoperative transfusions

Transfusions in the sample. As illustrated in Figure 2, eighty patients (35%) of the

s
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sample received blood transfusions in the hospital during the postoperative period. Twenty-four
patients (10%) participated in the autologous donation program and donated either one or two
units preoperatively. Twenty-one (9%) patients donated two units. Twelve (5%) patients
received both units, four (1.8%) patients received one unit, and five (2%) patients did not receive
any PAD units in the postoperative period. Three (1.3%) patients donated and received one PAD
unit postoperatively. In total, forty-five units of PAD blood were donated, 68% of these were
transfused while fourteen (31%) of these units were not transfused and therefore, wasted.
Sixty-two patients (26%) were transfused with allogeneic blood following their surgery.
Thirty (13%) patients received one unit; twenty-five (11%) were transfused with two units; four
(1.8%) patients required three units while one patient each was transfused with four, five and six
units.
Two (1%) patients who had participated in the PAD program received their two units in
return and required an additional allogeneic unit.
Figure 2: Detail of Postoperative Transfusions in Total Hip and Total Knee
N ot Transfused versus Transfused (n=2 28)
60 , 26 %
No t Tran sf u sed
1 48, 65 %

Tran sf used - Au t o logo u s

80, 35 %

Tran sf used - Allo ge ne ic
Tran sf used - Bo t h
1 8, 8 %

2, 1 %

Surgical Su bject s

Research question 2.What risk factors were associated with postoperative blood
transfusion? Chi Square tests were completed on each of the demographic and factor variables on
transfusions. Significant results were found in several areas. Female gender significantly
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impacted postoperative transfusions (χ 2= 4.29, p=.038). Older age was also a factor in
postoperative transfusions (χ 2= 7.88, p=.049). Fifty one percent of the patients who received a
transfusion were in the age range of 66 to 79 years. Length of stay indicated blood transfusion
was not associated with longer stays (χ 2 =13.57, p<.001). There was a statistical significance
between having a hematological comorbid condition and receiving postoperative transfusion (χ 2
=4.13, p=.042). Diabetes Mellitus as a co morbid condition, while not statistically significant,
does point to a relationship factor for transfusions. A borderline statistically significant
relationship was also noted between those not using preoperative iron and the need for a
postoperative blood transfusion (χ 2 =3.81, p=.051).
Table 4 Chi Square Analysis of Selected Factors Compared to Postoperative Blood Transfusion
Use
Demographic and
risk factors
Age Groups
< 50
51-65
66-79
80+
Gender
Female
Male
Length of Stay
Short 1-3 days
Long 4+days
Hematological
disease
no
yes
Diabetes mellitus
no
yes
IV or oral iron
no
yes

χ2

Transfused n
(%)
No

Transfused n
(%)
Yes

Totals N=228
(%)

16 (10.8)
68 (45.9)
51 (34.5)
13 (8.8)

5 (6.3)
25 (31.3)
41 (51.3)
9 (11.3)

21 (9.2)
93 (40.8)
92 (40.4)
22 (9.6)

95 (64.2)
53 (35.8)

62 (77.5)
18 (22.5)

157 (68.9)
71 (31.1)

4.29, p=.038

113 (76.4)
35 (23.6)

42 (52.5)
38 (47.5)

155 (68)
73 (32)

13.57, p<.001

144 (97.3)
4 (2.7)

73 (91.3)
7 (8.8)

217 (95.2)
11 (4.8)

4.13, p=.042

126 (85.1)
22 (14.9)

60 (75)
20 (25)

186 (81.6)
42 (18.4)

3.55, p=.060

139 (93.9)
9 (6.1)

69 (86.3)
11 (13.8)

208 (91.2)
20 (8.8)

7.88, p=.049

3.81, p=.051
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Research question 3. What was the rate of change in postoperative hemoglobin levels by
surgical type over the initial postoperative days? A general linear model was used to compare
preoperative hemoglobin lab results with postoperative sequential hemoglobin lab results for hip
and knee subjects. There exists heterogeneity in the measures of within subject effects; therefore,
the Huynh-Feldt statistic was used to detect the effect. The observed F ratio was statistically
significant F (2,103) = 58.67, p < .001. In comparing TKA and THA surgical procedures in this
patient sample, there is no statistically significant difference in hemoglobin levels in the
postoperative period. However, there is a statistically significant decrease in hemoglobin levels
in both surgical procedures from baseline hemoglobin levels to a nadir hemoglobin level on
postoperative day three. As depicted in Figure 3, the hemoglobin levels for hip and knee
procedures reach a nadir on postoperative day three dropping approximately four grams.
Figure 3 Comparisons of Preoperative Hemoglobin Lab Results to Postoperative
Hemoglobin Lab Results for Total Hip and Total Knee Surgical Subjects

Hemoglobin Levels
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knee
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5
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1:preop
2: post op
3: post op
4: post op
5: post op
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day
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1
2
3
4
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Discussion of Results, Practice Algorithm, and Implications
Discussion of Results
The utilization of blood transfusions for elective TKA and THA is not a novel theme
isolated to this particular healthcare system; it continues to be a topic of research globally. This
sample of 228 patients who elected to have TKA and THA surgical procedures in this Midwest
healthcare system in the timeframe of January 1, 2009 through March 31, 2009 experienced
results similar to those reported in the current literature. The prevalence of anemia in elective
surgical patients is estimated to be 75% is some populations with a wide range from 5% to 76%
according to the literature (Goodnough, et. al., 2005; Kumar, 2009; Saleh, McClelland, Hay,
Semple, & Walsh, 2007). Forty patients (18%) in this sample were noted to have preoperative
anemia as defined by the WHO criteria, a conservative number. While WHO criteria are
recommended to assess anemia, a hemoglobin level of 13.0 g/dL or greater is suggested as a
starting point for those who elect to have TKA and THA procedures (Keating, et al., 1998).
Applying 13.0 g/dL as the baseline hemoglobin level for men and women would likely result in a
larger number of patients in this sample who qualify for preoperative interventions. An estimated
35% of those scheduled to have elective TKA and THA procedures have preoperative
hemoglobin levels less that 13.0 g/dL, nationally (Goodnough et. al, 2005).
Preoperative anemia is associated with a higher risk of postoperative transfusions
(Keating, et. al., 1998). Similarly, 75% of those noted to have preoperative anemia within this
sample, received a transfusion in the postoperative phase. In addition to preoperative anemia and
autologous donations, age may be a factor in predicting postoperative transfusions for patients
who elect to have TKA and THA procedures (Hepinstall, Colwell, & Macaulay, 2003). This
study demonstrated that female gender, age over 66, known diagnosis of anemia, lack of
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preoperative iron supplementation, and to a lesser degree a comorbid diagnosis of diabetes
mellitus were factors associated with postoperative blood transfusions.
Total knee arthroplasty and total hip arthroplasty procedures are associated with major
blood losses seen in a 3 to 5 gram hemoglobin decrease postoperatively (Keating, & Ritter,
2002). Falling in line with the literature, the results from this study sample demonstrated an
average decrease in hemoglobin level for TKA from 13.38 g/dL preoperatively to a nadir of 9.34
g/dL, a 4.04 g/dL loss. For the patients having THA procedures the average hemoglobin decrease
is 13.50 g/dL to 9.39 g/dL, a 4.11 g/dL drop. The literature supports longer hospitalizations for
those patients who receive postoperative transfusions (Bierbaum, et al., 1999). However, even
with this hemoglobin drop from preoperative to postoperative day three, and the resulting thirtyfive percent transfusion rate, the length of stay in the study sample favors three days over a
longer hospitalization. One way to decrease the costs associated with these procedure is to
reduce the hospital stay. Further research is needed to determine how that shortened length of
stay in the acute setting influences patient and financial outcomes for the entire episode of care.
The data from this study may not be generalizable due to the ethnicity of the surgical
subjects. The fact that this sample is comprised of mostly Caucasian women is intriguing and
raises another set of research questions, especially when this particular healthcare system is
located near a large metropolitan area with a diversified population. This is of further interest
because TKA and THA are elective procedures, increasing in frequency, performed for pain and
immobility related to joint failure most commonly for arthritis; incongruently, arthritis is noted to
have a disproportionate burden in minority populations, women, the elderly, and those
compromised due to a lack of education, employment, and income (Marks & Allegrante, 2007).
Arthritis is a condition associated with chronic pain and physical impairment, often robbing
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persons of the mobility essential to availing oneself of societal goods, and thus impacting access
to health and health care (Mackenzie, Miller, & Fins, 2005, p.7). Healthcare providers from an
ethical perspective of justice share the responsibility of alleviating pain and functional limitations
associated with diseases such as arthritis, thus promoting the common good in all communities.
Gap analysis. Taking into account the study results and literature, there are opportunities
to improve the care for patients who elect to have TKA and THA procedures within this
healthcare system. Identified gaps highlighting the need for change include:
•

The lack of assessment and correction of preoperative anemia leading to the need for
postoperative transfusions - a patient safety issue

•

Allowances for autologous donation (PAD), a practice that is being discouraged due
to its association with increased preoperative anemia, high costs and wastage - a
resource utilization issue, and, as with all transfusions, patient safety issues

•

The use of allogeneic blood transfusions, without a clearly defined blood
conservation protocol - a matter of distributive justice, resource utilization,
stewardship, and evidenced based quality care

Creating a Practice Algorithm
Algorithms. Practice tools, such as algorithms can be designed to guide decisions to
correct preoperative anemia and thereby decrease postoperative transfusions in patients who
elect to have TKA and THA procedures. In the overall scope of a blood management program,
the utilization of algorithms may seem minuscule. Nel (2008) notes that it is better to start with
an elementary approach designated to be modifiable, while crafting a culture of continuous
quality improvement with the goal of safe and efficient use of the blood supply.
In fact, there are many examples of algorithms and pathways being successfully used
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globally to change practice patterns. Goodnough and colleagues (2005) developed a pathway as
a multidisciplinary physician group to assist in the process of detecting, evaluating, and
managing preoperative anemia. It begins with a complete blood count and differential thirty days
preoperatively. Any abnormal hemoglobin level is evaluated according to the cell indices, and
strategies to rectify the anemia are taken. Interventions to correct anemia are based on the
underlying cause and may include vitamin B12 injections, oral or intravenous iron
supplementation, and/or consultative services with gastroenterologists or nephrologists
(Goodnough, et al., 2005)
In a 2005 review of blood management issues associated with total joint arthroplasty,
Callaghan, O’Rourke, and Liu, shared an algorithm from their practice adapted from Pierson,
Hannon, and Earles (2004). The algorithm outlines options individualized for the patient. Based
on the preoperative hemoglobin and the anticipated surgical procedure, expected hemoglobin
losses are calculated which offer the lowest predictable postoperative hemoglobin level. With a
threshold of 8.0 g/dL, preoperative interventions of autologous donation or epoetin alfa
injections are recommended based on the calculated lowest hemoglobin level. This approach
allows for current scientific information regarding blood management for total joint surgeries to
be applied in a patient-specific manner (Callaghan, O’Rourke, & Liu, 2005).
Development and impact of a one-page flow chart to guide blood transfusions practice in
total joint patient experiences was the focus of study in Switzerland by Müller, Exadaktylos,
Roeder, Pisan, Eggli, and Jüni (2004). The flow chart was simple in design, widely distributed,
endorsed by local leaders, and developed by the staff, which added to the ownership. The
practice changes seen with the flow chart demonstrated a decrease in allogeneic transfusions
from 35% to 20% and a decrease in the use of autologous blood from 29% to 6% (Müller,
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Exadaktylos, Roeder, Pisan, Eggli, & Jüni, 2004).
In France, Martinez, Monsaingeon-Lion, Cherif, Judet, Chauvin, and Fletcher (2007)
developed and successfully used an algorithm as part of a quality improvement program to yield
a 50% decrease in postoperative transfusions. The algorithm consisted of calculation of expected
losses with the surgical procedure and tolerated losses expressed in a mathematical equation. If
the calculation resulted in expected losses being greater than the tolerated losses for the
individual patient, then a transfusion-sparing procedure was recommended. Interestingly, the
normal practice for this patient population includes a preoperative consultation with an
anesthesiologist one month prior to surgery. Development of the algorithm ensured that the
surgeon ordered a complete blood count, which was then available at this patient visit allowing
the anesthesiologist time to analyze and implement of the most appropriate strategy to limit the
use of transfusions based on the calculations. Transfusion-sparing strategies included the use
preoperative epoetin alfa, prudent use of autologous blood donation, red blood cell salvage, or a
combination of these strategies resulting in not only cost-neutrality, but in medical and quality
improvements in care.
Advocating for patient-specific strategies (PSS), Stulberg and Zadzilka, (2007) outlined
strategies in the preoperative, intraoperative, and postoperative phases of total joint surgery,
which can be employed for blood management. Preoperatively, a baseline hemoglobin three
weeks before surgery is recommended with treatment using epoetin alfa as warranted to boost
the hemoglobin. They do not recommend autologous donation due to associated preoperative
anemia, cost, and wastage. Pulling together outlined strategies with a planned blood management
program for total joint surgeries, they realized PAD decreases of 117 units in 226 patients, a
20% drop in transfusion rate, and greater than $50,000 savings in one year (Stulberg & Zadzilka,
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2007).
Proposed algorithm. Figure 4 is the initial algorithm proposed for practice within this
setting. It is designed to serve as a tool guiding the assessment and management of preoperative
anemia for elective surgical procedures with an anticipated blood loss of three units of blood or
greater. The goal is in line with the first pillar identified in blood conservation strategies namely,
maximizing preoperative red blood cell mass (Gombotz, Rehak, Shander, & Hofmann, 2007).

Running head: ANEMIA MANAGEMENT AND TOTAL JOINT SURGERIES

39

Figure 4: Algorithm for Assessment and Management of Pre-operative Anemia for
Elective Surgical Procedures Anticipating Blood Loss of > 3 Units of Blood

GOAL: Maximize preoperative red blood cells

Hemoglobin
>13.0 g/dL
Factors to consider:
• Total knee
 Total
knee
and total
and
hip total hip
replacement
surgeries
associated
with 3-5
gram
hemoglobin
drop
• Age
• Gender
• Ethnicity
Ethnicity
• Co
Co morbid
morbid
conditions
conditions

Preoperative
laboratory
tests
including a
Complete
Blood Count
30 days
before
elective
surgery

Hemoglobin
<13.0 g/dL
Refer to
anemia clinic
or infusion
center

Anemia Evaluation
(Check and document
indices prior to epoetin
alfa therapy)
√
√
√
√
√

Vitamin B12
Folic Acid level
RBC indices
Reticulocyte count
Iron parameters:
- Serum iron
- TIBC
- %Transferrin sat
- Serum ferritin
√Stool occult blood
Correct other problems
prior to epoetin initiation

Preautologous
Donation of blood
only if know multiple
antibodies (difficult
type and cross match)
or patient demand

Macrocytic:
If ↓ B12 : give
B12 1000 mcg
in 4 weekly
doses
↓ folate: begin
Oral folic acid
Normocytic:
epoetin alfa in
monitored
setting pre op
day 21, 14 & 7
Microcytic:
↓ iron studies:
IV iron

If Iron studies
(TSAT < 20%
and / or Ferritin
<100). Replete
with IV iron prior
to epoetin alfa

Monitor
patient
results. If
not
responding
notify
physician.
Referral to
Hematology

Stools guiac +,
refer to
gastroenterology

** Remind patient to stop medications that can hinder coagulation prior to surgery
as ordered, including prescription, over the counter, and herbal supplements

Running head: ANEMIA MANAGEMENT AND TOTAL JOINT SURGERIES

40

Key characteristics verified by the literature and the sample surgical patients from the
study help frame the algorithm. TKA and THA procedures are associated with 3 to 5 grams of
hemoglobin loss. Additionally, age, ethnicity, gender, and comorbid conditions can increase the
likelihood that patients may have preoperative anemia. Preoperative blood work done thirty days
before the scheduled surgery that includes a CBC is warranted, so that preoperative anemia can
be corrected prior to the surgery. This is not a current practice pattern within this particular
healthcare system. Results from the patients in the sample demonstrated that timing of the
preoperative CBC is closer to the surgical procedure than the recommended thirty-day window
needed to treat noted anemia. Of the 228 patients, 50% had their blood tests completed in a
window of seven to ten days prior to surgery. Another 44% had their blood tests completed in
days 11 to 29 days preoperatively. Only 6% had a known preoperative hemoglobin level done
thirty days prior to surgery.
If the hemoglobin in noted to be above 13.0g/dL, PAD should not be offered as an option
with exceptions made for patients with known antibodies and/or those who firmly demand to use
this process (Kumar, 2009). The literature demonstrates that this practice is not beneficial due to
time inefficiencies for patients and the laboratory personnel, associated costs, wastage of the
units not utilized, and preoperative anemia noted in those who donated in advance of their
surgical procedure (Bierbaum et al., 1999).
If the hemoglobin level is below 13.0 g/dL, further studies are warranted to ascertain the
reason for preoperative anemia. Algorithms used for assessing and treating preoperative anemia
differentiate the condition using the red blood cell indices, specifically the mean corpuscular
volume (MCV) to determine if the anemia is macrocytic, microcytic, or normocytic. In
macrocytic anemia, the MCV is greater than 100 fl suggestive of vitamin B12 or folate
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deficiency. Microcytic anemia with an MCV less that 80 fl suggests an iron deficiency.
Normocytic anemia is defined when the MCV is in the 80 to 100 fl range. Supplementing with
folate, B12, or iron is recommended to correct the anemic condition (Goodnough, et. al 2005).
If iron deficiency is noted, it can be corrected with intravenous (IV) iron. There are IV
iron preparations that are safe, efficient, and effective. The IV route of administration is
recommended when the patient is intolerant of oral iron preparations, or when there is inadequate
time for oral agents to respond (Cuenca, García-Erce, & Muñoz, 2008). The time to surgery for
oral iron to be effective is 30 – 45 days (Cuenca, García-Erce, Muñoz, Izuel, Martínez, &
Herrera, 2004).
The treatment of preoperative iron deficiency anemia in patients undergoing orthopedic
surgery was the subject of a prospective study done in Switzerland by Theusinger, Leyvraz,
Schanz, Seifert, and Spahn (2007). A noted 21% of the patients undergoing elective major
orthopedic surgeries had iron deficient anemia and were treated with 900 mg of IV iron sucrose
over the course of ten days four weeks before surgery. A significant increase in hemoglobin was
noted (p < 0.0001) with the mean maximum increase of 1.0 + 0.6 g/dl. This peak hemoglobin
was seen two weeks after the initiation of IV iron, but the increase was not sustained throughout
the surgical episode. Eight of the twenty patients required perioperative transfusions. The authors
speculate the endogenous erythropoietin decrease, which accompanied the hemoglobin increase,
is the reason for this response and therefore, recommend the IV iron two weeks preoperatively
(Theusinger, et al., 2007).
If normocytic anemia is detected and/or the use of IV iron does not increase the
hemoglobin above 13.0 g/dL, epoetin alfa (EPO) is recommended. Epoetin alfa is indicated for
use preoperatively in total joint replacement surgical patients to boost red blood cell production
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in those patients found to have preoperative anemia. While expensive, this medication has been
shown to decrease the use of blood transfusions postoperatively in patients who electively have
THA and TKA surgical procedures (Cushner, Lee, Scuderi, Arsht, & Scott, 2006). Epoetin alfa
use for preoperative anemia has been studied and is in use globally.
In one study using EPO (Rosencher, Poisson, Albi, Aperce, Barre, & Samama, 2005) the
number of EPO injections required to reach a hematocrit of 40% in moderately anemic patients
was compared to the use of autologous blood donations. This study received financial support
from Janssen-Cilag Laboratory and was stimulated by a recommendation from the French
authorities that allogeneic transfusions be limited to life threatening situations and alternative
therapeutic strategies be used for all other patient care. Outcomes demonstrated that those
patients who were given epoetin alfa preoperatively had a higher volume of red blood cell (RBC)
production, and had a significantly higher hematocrit on days one and three after surgery and at
discharge. These patients also had better energy scores as measured by questions on fatigue,
headaches, malaise, nausea, palpitations, and dyspnea, and they required less transfusion. Two
injections of epoetin alfa were sufficient in most cases to reach goal, thus lowering the associated
transfusion expenses. While both the use of epoetin alfa and PAD aim to decrease the use of
allogeneic transfusions, the study noted that interventions should be individualized based on
erythrocyte volume and predicted total blood loss (Rosencher, et al., 2005).
In another Canadian study, with grant support from Janssen-Ortho Inc., a random double
blind multicenter trial was designed to examine two modified dose regimens of epoetin alfa with
placebo. The factors under study were EPO dosing, the use of allogeneic transfusions, and
thromboembolic events. The study involved thirteen teaching hospitals, four community
hospitals, and a patient population that was ineligible for PAD. A total of 201 THA patients
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with preoperative hemoglobin levels 98 to 137 grams were assigned to one of three groups.
Group one was treated with 40,000 units of subcutaneous epoetin alfa preoperatively for four
weeks. Group two received 20,000 units of epoetin alfa a total of four weeks preoperatively and
the third group was treated with placebo. All of the patients were given oral iron in the amount of
450 grams for 42 days or more preoperatively. Hemoglobin levels, reticulocyte counts, and
doppler studies of lower extremities were compared. This study found that patients who received
EPO needed significantly less blood and had better hematological responses than those treated
with placebo. Patients dosed with 40,000 units of EPO had lower transfusion rates than those
treated with 20,000 units. The incidence of thromboembolic events did not differ (Feagan, et al.,
2000).
Attempting to study the use of epoetin alfa in the elderly, Lofthouse, Boitano, Davis, and
Jinnah (2000) compared its use preoperatively for patients seventy years of age or older having
major elective orthopedic surgeries with a matched group as control. Using an open-label,
nonrandomized, parallel group study, control patients were matched for age, history, and surgical
procedures. The study group protocol utilized 40,000 units of EPO given in two doses to patients
in need of TKA and three doses for those having THA surgery. All patients received oral iron for
at least fourteen days preoperatively. End points of the study were pre and postoperative
hemoglobin and hematocrit levels and transfusion requirements. Transfusion triggers for the
study remained at 10 g/dL. The study group had 12.5% use of blood transfusions as compared to
the control group, which had a 74% use of blood transfusions. Epoetin alfa was deemed safe and
efficient when used preoperatively in the elderly who elective to have TKA or THA according to
this study, which noted no hematologic complications in the study group (Lofthouse, Boitano,
Davis, & Jinnah, 2000).
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Epoetin alfa has an indication for use preoperatively in anemic patients who elect to have
THA and TKA procedures for the purpose of increasing red blood cell volume. As with all
medications, there are safety concerns with EPO. In this indication, it is recommended that EPO
only be used with prophylactic anticoagulation, due to the increased risk of thromboembolic
events (Kumar, 2009). In one prospective, open-label, randomized study specifically looking at
the use of EPO in patients with spine surgery without the use of prophylactic anticoagulation, a
higher rate of deep vein thrombosis was found in those treated with EPO when compared to a
control group (Stowell, Jones, Enny, Landholff, & Leitz, 2009). One case study further illustrates
the fact that hemoglobin levels need to be closely monitored while patients are receiving EPO.
This particular patient was treated both preoperatively and postoperatively with EPO, at 10,000
units daily as well as prophylactic anticoagulation therapy for her orthopedic surgery. On
postoperative day eight, with complaints of chest pain, she was transferred to the intensive care
unit where a hematocrit level of 48% was noted and further tests revealed a ventricular thrombus.
The authors recommend monitoring of blood counts with the use of EPO (Karabinos, et al.,
2007).
Interventions to correct preoperative anemia and to maximize red blood cell volume take
time, assessment skills, and ongoing monitoring. If the assessment reveals guiac positive stools,
then a gastroenterological workup is warranted. Likewise, in the course of treatment, if the
patient is not responding with an increasing hemoglobin level, then the team deserves timely
notification so that other interventions can be ordered. There are anemia management clinics is
place within this particular healthcare system which are specifically designed to assist the team
in the management of preoperative anemia. These clinics have standard order sets, utilize point
of care hemoglobin testing equipment, and are associated with a high level of patient satisfaction.
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Implications for Practice
This change project was designed from inquiry between two professionals interested in
the impact of preoperative anemia on postoperative blood transfusions for patients who
electively have TKA and THA surgical procedures. Truly, there are opportunities to influence
patient care with improvements that can make the surgical experience for TKA and THA
procedures safer and more satisfying. Clinical and technical knowledge regarding these surgical
procedures continues to evolve. Hence, there is a need for those involved in the care of these
patients to stay focused on analysis of the research. This analysis should lead to necessary
practice changes primarily for the sake of patient care, but also to remain competitive in the
marketplace.
There are many members of the healthcare team assigned to total joint replacement
surgeries. It is essential for the team to learn from one another, to form a common everexpanding worldview while remaining focused on the value of creating the best patient
experience. Decision-making, problem solving, and evaluating practice as a team is crucial in
this rapidly changing healthcare environment. Teams who can accomplish these tasks will set the
stage for patient care that is clinically excellent and up-to-date, and will therefore remain
competitive. This study, completed by an advanced practice nurse, is but one example of
reviewing current practice with the goal of informing the team of opportunities to improve
patient care for those who elect to have TKA and THA procedures in this healthcare setting.
Costs and Benefits
The project would not be complete without attention to the costs and benefits associated
with the recommended changes in practice. Understanding the financial risk involved in clinical
change projects is essential in these economically strained times. It is essential to keep in mind
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that anemia is a multiplier of morbidity and mortality and therefore deserves attention (Kumar,
2009). The costs and benefits of preoperative medications to correct anemia for elective surgery
need to be compared to the use of blood transfusions postoperatively. The administration of EPO
and IV iron preoperatively, appropriately monitored, are safe and effective in increasing red
blood cells. There are significant expenses associated with the use of these medications. That
expense needs to be balanced against the use of blood transfusions for elective surgeries, which
is a complicated task. It is hard to get a handle on the exact cost of a unit of allogeneic blood and
the treatment of potential resulting adverse effects, but the associated monies for a unit of blood
will increase with further safety testing and shortages. In looking at the costs of epogen over the
use of allogeneic transfusions, Keating, Callaghan, Ranawat, Bhirangi and Ranawat (2007) note
that it would be inappropriate to recommend allogeneic transfusion over EPO simply on the basis
of direct cost. Blood transfusions may be more costly than blood conservation efforts when the
calculation includes the risks and scarcity of blood, the liability associated with transfusion
errors, and the costs of testing, storing, and transfusing blood (Keating, Callaghan, Ranawat,
Bhirangi & Ranawat 2007, p. 331-332)
The case for conserving blood is compelling according to Longjohn, Dorr, McPherson
(1999); because shortages are common, there is a shrinking donor pool, and surgeries around the
nation have been canceled due to the unavailability of blood. This necessitates judicious
utilization. From a safety standpoint, every unit of blood transfused has associated risks, even
when closely monitored. From an institutional aspect, Joint Commission plans to implement a
performance measure surrounding blood utilization and conservation necessitating interventions,
such as a preoperative algorithm to prove compliance (Joint Commission Accreditation of
Healthcare Organizations, 2007).
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Conclusion
In summary, this particular change project challenges providers engaged in the practice
of providing care to patients who elect to have TKA or THA surgical procedures to reexamine
the patient care experience in light of best practices, particularly those related to reducing
preoperative anemia and postoperative transfusions. There are strategies that can enhance the
surgical experience, making it safer for patients and more ethically sound and socially just for
providers.
Next Steps
Moving the change process forward will involve a number of steps. Weaving the Human
Systems Theory into the change process will be vital to setting the tone for team participation.
The seven basic human operations of learning, constructing worldview, constructing ideal
pattern, conceptualization, creating climate, creating environment, and cybernetics serve to
establish the human group, the health care team. Engaging team members to learn from this
research will take place through a variety of dissemination methods, some written and some oral.
The research will serve to demonstrate how the worldview can be expanded and practice
enhanced by incorporating evidence-based knowledge from a global perspective. United in
professional values to deliver quality, safe, effective, efficient care in a fiscally responsible
manner within the health care system drives a common ideal pattern for team members.
Implementation of the algorithm will involve intention, planning, decision-making, problem
solving, and evaluation, in essence, all of the steps from the human process of conceptualization.
The work to create a climate and environment, which is conducive to autonomous professionals
uniting in ongoing collaboration, cannot be underestimated. If this, in fact, is possible the
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synergy that pours out from such teamwork will ensure achievement of mission, vision, values,
and sustained marketability for the system.

Running head: ANEMIA MANAGEMENT AND TOTAL JOINT SURGERIES

49

References
Bierbaum, B. E., Callaghan, J. J., Galante, J. O., Rubash, H. E. Tooms, R. E., & Welch, R.B.,
(1999). An analysis of blood management in patients having a total hip of knee
arthroplasty. The Journal of Bone and Joint Surgery, 81-A (1), 2-10.
Billote, D.B., Glisson, S.N., Green, D., & Wixson. R.L., (2002) A prospective, randomized
study of preoperative autologous donation for hip replacement surgery. The Journal of
Bone and Joint Surgery, 84, 1299-1304.
Boucher, B.A., & Hannon, T.J. (2007). Blood management: A primer for clinicians.
Pharmacotherapy 27(10), Retrieved from:
http://www.medscape.com/viewarticle/564606_print
Callaghan, J.J., O’Rourke, M.R., & Liu, S.S., (2005). Blood management issues and options. The
Journal of Arthroplasty 20(4) Suppl. 2, 51-54. doi:10.1016/j.artg.2005.03.018
Cook, J. R., Warren, M., Ganley, K.J., Prefontaine, P., & Wylie, J.W., (2008) A comprehensive
joint replacement program for total knee arthroplasty: A descriptive study. BMC
Musculoskeletal Disorders, 9 (154), doi: 10.1186/147-2474-9-154
Cuenca, J., García-Erce, J.A., & Muñoz, J. (2008) Efficacy of intravenous iron sucrose
administration for correcting preoperative anemia in patients scheduled for major
orthopedic surgery Anesthesiology, 109(1), 151-152.
Cuenca, J., García-Erce, J.A., Muñoz, J., Izuel, M., Martinez, A.A., & Herrera, A (2004) Patients
with pertrochanteric hip fracture may benefit from preoperative intravenous iron therapy:
A pilot study. Transfusion, 44, 1447-52.
Cushner, F.D., Lee, G., Scuderi, G.R., Ascht, S.J., & Scott, W.N. (2006). Blood loss
management in high-risk patients undergoing total knee arthroplasty: A comparison of

Running head: ANEMIA MANAGEMENT AND TOTAL JOINT SURGERIES

50

two techniques. The Journal of Knee Surgery, 19(4), 249-253.
Diamond, P.T., Conaway, M.R., Mody, S.H., & Bhirangi, K., (2006). Influence of hemoglobin
levels on inpatient rehabilitation outcomes after total knee arthroplasty. The Journal of
Arthroplasty, 21(5), 636-641.
Ershler, W.B., Chen, K., Reyes, E.B., & Dubois, R., (2005). Economic burden of patients with
anemia in selected diseases. Value in Health, 8(6), 629-638. doi:10.1111/j.15244733.2005.00058.x
Feagan, B. G., Wong, C. J., Kirkely, A., Johnston, D. W. C., Smith, F. C., Whitsitt, P., …. &
Lau, C.Y. (2000). Erythropoietin with iron supplementation to prevent allogeneic blood
transfusion in total hip joint arthroplasty. Annals of Internal Medicine, 133(11), 845-854.
Retrieved from: www.annals.org.
Gombotz, H., Rehak, P. H., Shander, A., & Hofmann, A. (2007). Blood use in elective surgery:
The Austrian benchmark study. Transfusion, 47, 1468-1480. dio: 10.1111.j.15372995.2007.01286.x
Goodnough, L.T., Shander, A., Spivak, J.L., Waters, J.H., Friedman, A.J., Carson, J.L…, &
Spence, R. (2005). Detection, evaluation, and management of anemia in the elective
surgical patient. Anesthesia & Analgesia, 101, 1858-1861.
doi:10.1213/01.ANE.0000184124.29397.EB
Goodnough, L.T., Shander, A., and Spence, R. (2003). Bloodless medicine: clinical care without
allogeneic blood transfusion. Transfusion 43 (19), 668-676.
Hanlon, J.M. (1968). Administration and education. Belmont, CA: Wadsworth.
Hatzidakis, A.M., Mendlick, R.M., McKillip, T., Reddy, R.L., & Garvin, K.L. (2000).
Preoperative autologous donation for total joint arthroplasy. The Journal of Bone and

Running head: ANEMIA MANAGEMENT AND TOTAL JOINT SURGERIES

51

Joint Surgery, 82-A(1), 89 – 100.
Hepinstall, M.S., Colwell, C.W., & Macaulay, W.B. (2003). Blood conservation in primary hip
arthroplasty. Journal of the Southern Orthopaedic Association, 12(2), 95-102.
Holdener, K.E. & Liang, X. (2007). An overview of anemia and its management: What the
pharmacist need to know. Journal of the Pharmacy Society of Wisconsin, March/ April,
13-21.
Joint Commission Accreditation of Healthcare Organizations (2007). Joint commission
perspectives of patient safety. Joint Commission Resource Publication, 7(1), 1-12.
Karabinos, I.K., Koulouris, S., Kranidis, A., Ali, M.E., Marsonis, A., Kokkinou, V., &
Exadaktylos, N. (2007). Spontaneous thrombus formation in a normal left ventricle
following administration of large doses of epoetin. Hellenic Journal of Cardiology, 48,
44-46.
Keating, E.M., Callaghan, J.J., Ranawat, A.S., Bhirangi, K., & Ranawat, C.S. (2007). A
randomized, parallel-group, open-label trial of recombinant human erythropoietin vs.
preoperative autologous donation in primary total joint arthroplasty. The Journal of
Arthroplasty, 22(3), 325-333. doi: 10.1016/j.arth.2006.11.002
Keating, E.M. & Meding, J.B. (2002). Perioperative blood management practices in elective
orthopaedic surgery. Journal of the American Academy of Orthopaedic Surgeon’s 10(6),
393-400.
Keating, E.M., Meding, J.B., Faris, P.M., & Ritter, M.A. (1998). Predictors of transfusion risk in
elective knee surgery. Clinical Orthopaedics and Related Research, 357, 50-59.
Keating, E,M., & Ritter, M.A. (2002). Transfusion options in total joint arthroplasty. The Journal
of Arthroplasty, 17(4), 125-128. doi:10.1054/arth.2002.32459

Running head: ANEMIA MANAGEMENT AND TOTAL JOINT SURGERIES

52

Kickler, T.S. (2003). Editorial: Why “bloodless medicine” and how should we do it?
Transfusion, 43, 550-551.
Killip, S., Bennett, J.M., & Chambers, M.D. (2007). Iron deficiency anemia. American Family
Physician, 75(5), 671-78. Retrieved from: www.aafp.org/afp
Koch, C.G., Li, L., Sessler, D.I., Figueroa, P., Hoeltge, G. A., Mihaljevic, T., & Blackstone, E.H.
(2008). Duration of red-cell storage and complications after cardiac surgery. The New
England Journal of Medicine, 358, 1229-39.
Kumar, A., (2009). Perioperative management of anemia: limits of blood transfusion and
alternatives to it. Cleveland Clinic Journal of Medicine, 76, supplement 4, s112-s118.
Kumar, A.; & Carson, J.L. (2008). Perioperative anemia in the elderly Clinical Geriatric
Medicine, 24, 641-648. doi:10.1016/j.cger.2008.07.003
Lemaire, R. (2008) Strategies for blood management in orthopaedic and trauma surgery The
Journal of Bone and Joint Surgery (Br,) 90, 1128-36. doi:10.1302/0301620X.90B9.21115
Liang, M.H., Cullen, K.E., Larson, M.G., Thompson, M.S., Schwartz, J., Fossel, A.H., Roberts,
W.N., & Sledge, C.B. (1986) Cost-effectiveness of total joint arthroplasty in
osteoarthritis. Arthritis & Rheumatism, 29(8), 937-943.
Lofthouse, R. A., Boitano, M. A., Davis, J. R., & Jinnah, R. H. (2000). Preoperative
administration of epoetin alfa to reduce transfusion requirements in elderly patients
having primary total hip or knee reconstruction. Journal of Southern Orthopaedic
Association 9(3). Retrieved from: http://www.medscape.com/viewarticle/410438
Lonner, J.H. & Deirmengian, C.A. (2007). What’s new in adult reconstructive knee surgery The
Journal of Bone and Joint Surgery, 89(12), 2828-2837. doi:10.2106/JBJS.G.01232

Running head: ANEMIA MANAGEMENT AND TOTAL JOINT SURGERIES

53

Longjohn, D.B., Dorr, L.D. & McPherson, E.J., (1999) Commentary: Blood management
challenges in revision hip arthroplasty. Orthopedics, 22(1), s148-s150
Mackenzie, C. R., Miller, F. G., & Fins, J. J. (2005).Justice and health care in the rheumatic
diseases. Hospital for Special Surgery, 1(1), 58-63. doi: 10.1007/s11420-005-0108-0.
Retrieved from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2504135
Marks, R., & Allegrante, J. P. (2007). Prevalence and impact of arthritis: Opportunities for
prevention. Health Education Journal 66(1), 3-21 doi: 10.1177/001789690706936
Martinez, V., Monsaingeon-Lion, A., Cherif, K., Judet, T., Chauvin, M., & Fletcher, D. (2007).
Transfusion strategy for primary knee and hip arthroplasty: impact of an algorithm to
lower transfusion rates and hospital costs. British Journal of Anaesthesia, 99(6), 794-800.
doi:10.1093/bja/aem266
Monk, T.G. (2004). Preoperative recombinant human erythropoietin in anemic surgical patients
Critical Care 8(supplement 2), S45-S48. doi:10.1186/cc2824
Müller, U., Exadaktylos, A., Roeder, C., Pisan, M., Eggli, S., & Jüni, P. (2004). Quality
improvement report. Effect of a flow chart on use of blood transfusions in primary total
hip and knee replacement: prospective before and after study. BMJ, 328, 934-938. doi:
10.1136/bmj.328.7445.934
National Anemia Action Council (2009). Frequently asked questions. Retrieved from:
http://www.anemia.org/patients/faq
Nel, T.J. (2008). Clinical guidelines, audits and hemovigilance in managing blood transfusion
needs. Transfusion Alternatives in Transfusion Medicine 10(2), 61-69. Retrieved from:
http://www.medscape.com/viewarticle/580997_print
Pierson, J.L., Hannon, T.J., & Earles, D. R. (2004). A blood-conservation algorithm to reduce

Running head: ANEMIA MANAGEMENT AND TOTAL JOINT SURGERIES

54

blood transfusions after total hip and knee arthroplasty. The Journal of Bone and Joint
Surgery, 86(7), 1512-1518.
Rosencher, N., Poisson, D., Albi, A., Aperce, M., Barré, J., & Samama, C.M. (2005). Two
injections of erythropoietin correct moderate anemia in most patients awaiting orthopedic
surgery. Canadian Journal of Anesthesia, 52(2), 160-165.
Saleh, E.; McClelland, D.B.L.; Hay, A.; Semple, D., & Walsh, T.S. (2007). Prevalence of
anaemia before major joint arthroplasty and the potential impact of preoperative
investigation and correction on perioperative blood transfusions. British Journal of
Anaesthesia, 99(6), 801-8. doi: 10.1093/bja/aem299
Sehat, K.R., Evans, R.L., & Newman, J.H. (2004). Hidden blood loss following hip and knee
arthroplasty. The Journal of Bone and Joint Surgery (Br), 86(4), 561-565.
doi:10.1302/0301-620X.86B4.14508
Shander, A. & Goodnough, L.T. (2006). Objectives and limitations of bloodless medical care.
Current Opinion in Hematology, 13, 462-470.
Sinnen, M.T. (1981). A theory and model of nursing based on nurturance. (Unpublished masters
thesis). Marquette University College of Nursing, Milwaukee, WI.
Slappendel, R., Dirksen, R., Weber, E.W.G., & van der Schaaf, D.B., (2003). An algorithm to
reduce allogeneic red blood cell transfusions for major orthopedic surgery Acta
Orthopaedica, 74(5), 569-575. doi:10.1080/00016470310017974
Spahn, D.R. & Casutt, M. (2000). Eliminating blood transfusions: New aspects and perspectives.
Anesthesiology, 93(1), 242-55.
Stowell, C.P., Jones, S.C., Enny, C., Langholff, W., & Leitz, G. (2009). An open-label,
randomized, parallel-group study of perioperative epoetin alfa versus standard of care for

Running head: ANEMIA MANAGEMENT AND TOTAL JOINT SURGERIES

55

blood conservation in major elective spinal surgery: safety analysis. Spine, 34 (23), 24792485.
Stulberg, B.N. & Zadzilka, J. D., (2007). Blood management issues: using blood management
strategies. The Journal of Arthroplasty, 22(4) Suppl. 1, 95-98.
doi:10.1016/j.arth.2007.03.002
Theusinger, O.M., Leyvraz, P.F., Schanz, U., Seifert, B., & Spahn, D.R. (2007). Treatment of
iron deficiency anemia in orthopedic surgery with intravenous iron: efficacy and limits.
Anesthesiology, 107(6), 923-927.
Toy, P.T.C.Y., Kaplan, E.B., McVay, P.A., Lee, S.J., Strauss, R.G., Stehling, L.S., and the
preoperative autologous blood donation study group (1992). Blood loss and replacement
in total hip arthroplasty: a multicenter study. Transfusion, 32(1), 63-67.
World Health Organization (2008). Worldwide prevalence of anaemia 1993-2005: WHO global
database on anaemia. Eds. de Benoist, B. & McLean, E. ISBN 978 92 4 159665 7

Running head: ANEMIA MANAGEMENT AND TOTAL JOINT SURGERIES

56

Appendix A. Codebook. Improving Systems of Care to Manage Preoperative
Anemia and Postoperative Transfusions in Patients who Elect to have Total Knee or Total
Hip Surgery
Data Collection and Coding Sheet
Variable

Coding directly done to
computer excel spreadsheet
Data collected by researcher

Hospital

Method of data
collection
obtained by IT query

Last name
First name
Middle name/initial
MRI #
Account #
ID number for de-identified data
1- 228
Gender
Age
Ethnicity

obtained by IT query
obtained by IT query
obtained by IT query
obtained by IT query
obtained by IT query
manually created by
author
obtained by IT query
obtained by IT query
obtained by IT query

Pre-operative weight

manually extracted

Length of stay
Co morbid conditions
Cardiac disease
HTN
Rheumatoid arthritis
Diabetes mellitus
Chronic kidney disease
Pulmonary disease
Cancer
Hematologic disease
Liver disease
GI bleed
Neurologic disease / CVA
Preoperative medications:
Immunosuppressive agents
Anticoagulation agents
Epoetin alfa
IV or oral iron
IM or oral B12

obtained by IT query

Female (1) male (2)
Whole number
Native American (1)
Asian/Pacific Islander (2)
African American / Black
(3) Caucasian / White (4)
Hispanic (5) unknown (6)
Whole number + decimal
kilograms
Whole number

manually extracted
manually extracted
manually extracted
manually extracted
manually extracted
manually extracted
manually extracted
manually extracted
manually extracted
manually extracted
manually extracted

No (0) yes (1)
No (0) yes (1)
No (0) yes (1)
No (0) yes (1)
No (0) yes (1)
No (0) yes (1)
No (0) yes (1)
No (0) yes (1)
No (0) yes (1)
No (0) yes (1)
No (0) yes (1)

manually extracted
manually extracted
manually extracted
manually extracted
manually extracted

No (0) yes (1)
No (0) yes (1)
No (0) yes (1)
No (0) yes (1)
No (0) yes (1)

SFH (1) EMH (2) SJH (3)
OMIT
OMIT
OMIT
OMIT
OMIT
Whole number 1 to 228
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Surgical procedures:
Total hip (primary) (THA)
Total knee (primary) (TKA)
Revision hip (RH)
Revision knee (RK)
Bilateral hip (BH)
Bilateral knee (BK)
Orthopedic surgeon
ID number for de-identified data
Surgery
Estimated blood loss
Type of anesthesia
Blood tests
Preoperative hemoglobin
Preoperative hematocrit
Timing of preoperative CBC

Post op:
Day 1 hemoglobin
Day 1 hematocrit
Day 2 hemoglobin
Day 2 hematocrit
Day 3 hemoglobin
Day 3 hematocrit
Day 4 hemoglobin
Day 4 hematocrit
Transfusions
Preautologous donation number
of units
Transfused
Allogeneic number of units
Autologous number of units
Costs
Insurance

Charges
Transfusion charges
reimbursement

manually extracted

No (0) yes (1)

manually extracted

THA (1)
TKA (2)
RH (3)
RK (4)
BH (5)
BK (6)

manually created by
author

Whole number 1 through

manually extracted
manually extracted

Whole numbers in cc’s
General (0) spinal (1)

manually extracted
manually extracted
manually extracted

Number + decimal
Whole number (%)
7-10 days (1)
11-29 days (2)
30 days or longer (3)
Unknown (4)

manually extracted
manually extracted
manually extracted
manually extracted
manually extracted
manually extracted
manually extracted
manually extracted

Number + decimal
Whole number (%)
Number + decimal
Whole number (%)
Number + decimal
Whole number (%)
Number + decimal
Whole number (%)

manually extracted

Whole number

manually extracted
manually extracted
manually extracted

No (0) yes (1)
Whole number
Whole number

obtained by IT query

Self pay (1) Medicare (2)
Medicaid (3) Workers comp
(4) Commercial (5)
managed care (6)
Whole number
Whole number
Whole number

obtained by IT query
obtained by IT query
obtained by IT query
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